ZTE MRI Pulse Sequence Use for Visualization of Bone Cement, Breast Biopsy Markers
Launched by MAYO CLINIC · Mar 11, 2025
Trial Information
Current as of April 29, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new type of MRI imaging called ZTE imaging to see if it can better show breast biopsy markers made from bone cement compared to traditional markers that are made from metal. These biopsy markers help doctors locate areas in the breast that need closer examination, especially in patients with breast cancer. The goal is to see if this new imaging technique can improve the accuracy of these markers, which could help with better treatment planning.
To participate in the study, individuals must be at least 18 years old. However, there are some specific conditions that would exclude someone from joining, such as having a pacemaker, certain types of metal implants, or if they are pregnant. The trial is not yet recruiting participants, but it aims to involve people of all genders, specifically those who are between 65 and 74 years old. If eligible, participants can expect to undergo MRI scans using the new technique and will help researchers understand if it provides clearer images of the biopsy markers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age of 18 or older
- Exclusion Criteria:
- • Cardiac pacemaker
- • Implanted cardiac defibrillator
- • Internal pacing wires
- • Cerebral, carotid, or aortic aneurysmal clips
- • Cochlear implants
- • Implanted tissue expanders
- • Claustrophobia
- • Cannot lay prone
- • Pregnant
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Christine U. Lee, MD, PhD
Principal Investigator
Mayo Clinic in Rochester
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported